Seema Mohapatra, Françoise Baylis, and Natalie Kofler | August 24, 2021
As it could be onerous and cost-prohibitive in many settings to screen every patron, some businesses might reasonably introduce random checks. There is reason to fear that certain people, particularly people of color, will be scrutinized more closely than others.
Yvette d’Entremont interviews Françoise Baylis | June 2, 2021
“Everybody who cannot get one of these documents is going to experience a decrease in freedom relative to what others in the population can do,” bioethicist says
Françoise Baylis & Landon Getz | March 12, 2021
A troubling pattern has emerged during this pandemic where the needs and interests of youth and young adults appear to have been set aside. Here are three ways in which young adults are being uniquely affected in terms of access to vaccines, vaccination certificates, and challenge trials.
Françoise Baylis | February 16, 2021
Many people want to know who in their country will be the first to get the COVID-19 vaccine and where they are on the priority list. I am more interested in who should be the last to get the vaccine, and not only in rich countries that have early access to vaccines, but around the world.
Françoise Baylis & Landon Getz | November 17, 2020
with a number of promising vaccines in conventional Phase 3 trials, the federal government should reject the petition calling on it to “publicly announce a plan for COVID-19 human challenge trials.”
Françoise Baylis (propos recueillis par Nathaniel Herzberg) | 3 juin 2020
L’éthicienne et philosophe s’inquiète de l’impact sur notre vie privée de l’instauration d’un passeport immunitaire, alors que personne ne sait comment fonctionne l’immunité face au virus.
Françoise Baylis & Natalie Kofler | May 7, 2020
So-called immunity passports could create an intolerable biological divide between haves and have-nots.
Françoise Baylis | May 1, 2020
Imagine learning that a parent or sibling was denied access to a ventilator on the basis of age or disability, when they would have had access if they lived in a different province, or were at a different healthcare institution in the same province. Access to life-saving treatment should not be determined by geography.